mkulwiec

About mkulwiec

This author has not yet filled in any details.
So far mkulwiec has created 11 blog entries.

Bako Diagnostics Expands Clinical Utility of Nail Dystrophy Assay

2018-07-17T08:50:33+00:00

Media Contact: Aldo Nahed Communications@bakodx.com 470-695-3643 Ext. 283 ATLANTA — July 11, 2018 — Bako Diagnostics (BakoDx), the leader in nail dystrophy diagnostic testing, announced the availability of its expanded molecular test to include detection of the causative agent of green nail syndrome. Dr. Shari Lipner, assistant professor of dermatology at Weill Cornell Medicine, whose specialty is nail diseases, said she sees a lot of patients with onychomycosis along with another common problem — Pseudomonas aeruginosa — otherwise known as Green Nail Syndrome. “Pseudomonas nail infection is a very frustrating condition for patients because it’s often misdiagnosed,” Dr. Lipner said. [...]

Bako Diagnostics Expands Clinical Utility of Nail Dystrophy Assay2018-07-17T08:50:33+00:00

Bako Diagnostics Responds to Recent Statements Made by Dr. Bradley Bakotic

2018-06-26T08:18:38+00:00

ATLANTA. Jun. 26, 2018 – At Bako Diagnostics, among our highest priorities are upholding the quality and integrity of our work, maintaining the utmost professional standards, and ensuring that our company provides a safe workplace for our employees. As a result of false and misleading public statements being made by our former CEO, Dr. Bradley Bakotic, we now find it necessary to clarify the facts of his termination from Bako Diagnostics in an equally-public manner. Dr. Bakotic was terminated from Bako Diagnostics on September 8, 2017 after allegations of misconduct were made against him and following a comprehensive, independent investigation [...]

Bako Diagnostics Responds to Recent Statements Made by Dr. Bradley Bakotic2018-06-26T08:18:38+00:00

Bako Diagnostics Announces the Formation of Its Podiatric Advisory Board

2018-03-06T18:17:00+00:00

ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced today that they have formed a Podiatric Advisory Board to assist in implementing the Company’s current plans and identifying means to capitalize on future growth opportunities. The board will provide guidance in navigating, innovating, and growing the organization to carry out its mission of providing the highest quality laboratory services and products customized for the podiatric medical profession. The Advisory Board, which is comprised of distinguished podiatrists, educators, innovators, and scholars, includes Allen M. Jacobs, DPM (St. Louis, MO), Jeffrey D. Lehrman, DPM (Springfield, PA) [...]

Bako Diagnostics Announces the Formation of Its Podiatric Advisory Board2018-03-06T18:17:00+00:00

Bako Diagnostics Announces Appointments to Clinical Consultant Team – Podiatry Faculty

2018-03-06T18:16:09+00:00

ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced appointments to the Bako Clinical Consultant Team. This Team will represent Bako Diagnostics at various local, state, and national medical conferences, providing educational sessions and workshops. The Clinical Consultant Team, which is comprised of some of the most knowledgeable, accomplished, and dedicated podiatrists within the profession, includes: Javan S. Bass, DPM Lithonia, Georgia Robert M. Conenello, DPM Orangeburg, New York Andrew H. Cohen, DPM Saginaw, Michigan Brandon J. Hawkins, DPM Bakersfield, California LeRoy J. Kelley, III, DPM Norwood, Massachusetts Jeffrey D. Lehrman, DPM [...]

Bako Diagnostics Announces Appointments to Clinical Consultant Team – Podiatry Faculty2018-03-06T18:16:09+00:00

Bako Diagnostics Files Counterclaims in Lawsuit Against Former Management to Uphold Agreements and Recover Damages

2018-02-14T09:21:38+00:00

ATLANTA. Feb. 13, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced yesterday, that they filed counterclaims in the Superior Court of Delaware to uphold agreements with their former CEO, Dr. Bradley Bakotic, and former Medical Director, Dr. Jody Hackel, precluding them from competing with Bako Diagnostics, soliciting Bako employees or clients, using Bako’s confidential information, and otherwise intentionally causing harm to Bako’s business. Bako Diagnostics’ top priority is protecting the integrity of the company’s work to ensure delivery of the highest quality laboratory services and products to their valued customers. The counterclaims are vital to Bako’s [...]

Bako Diagnostics Files Counterclaims in Lawsuit Against Former Management to Uphold Agreements and Recover Damages2018-02-14T09:21:38+00:00

Bako Launches New Website for the Podiatric Community – bakodx.com

2017-12-20T10:45:09+00:00

Company changes name to Bako Diagnostics and redesigns logo to reflect increased clinical laboratory services for podiatrists ATLANTA. Dec. 15 /PRNewswire/ - Bako, a podiatry-focused clinical laboratory and products company, announced today the launch of its new website-bakodx.com, new company name and newly designed company logo. As a partner and advocate to the podiatric community, the website is designed to be a leading source of education, innovation and insight for podiatrists. The company’s new name and new logo reflects the evolution of the company from Bako Integrated Physician Services to Bako Diagnostics. “We are excited to launch this new site [...]

Bako Launches New Website for the Podiatric Community – bakodx.com2017-12-20T10:45:09+00:00

Biopsy Planning and Post-Biopsy Tissue Handling : A Synopsis

2017-11-24T19:22:22+00:00

Introduction As a general rule, the podiatic profession is notorious for its underutilization of cutaneous and soft tissue biopsy techniques. In some instances, such under-use may be attributed to trepidation stemming from a lack of familiarity with the biopsy techniques themselves; however, I believe this is not the preeminent cause. In my experience, the most common reason that many podiatric clinicians don’t use biopsy techniques to their fullest is a degree of insecurity regarding when to use witch biopsy and what to do with them once the biopsy has been performed. In most offices, the support staff is ill prepared [...]

Biopsy Planning and Post-Biopsy Tissue Handling : A Synopsis2017-11-24T19:22:22+00:00

Cutaneous Biopsy Techniques in the Management of Chronic Wounds

2017-11-24T19:32:38+00:00

Many clinicians rely exclusively on clinical acumen when determining how to manage chronic wounds. Though an ulcer’s clinical features may be fairly indicative of its etiology, in some instances, such is not the case. Even among the most characteristic‐appearing ulcerations, masqueraders do exist. Ruling out the possibility of an unsuspected neoplastic or inflammatory condition could be necessary for the successful management of chronic wounds. In this context, cutaneous biopsy techniques may be invaluable; however, their utility does not necessarily end here. There are three common clinical settings in which a biopsy may be used in the management of a chronic wound. [...]

Cutaneous Biopsy Techniques in the Management of Chronic Wounds2017-11-24T19:32:38+00:00

Needle Aspiration Biopsy

2017-11-25T09:16:05+00:00

Needle aspiration biopsy is amongst the most underutilized diagnostic procedures of those available. This technique may be effectively used to rule out high‐grade malignancies when faced with nonspecific subcutaneous masses, in particular, those masses that resemble ganglion cysts. I once had three different medico‐legal cases under consultative review at one time, all of which were centered on patients who had non‐specific ganglion‐like masses. In each instance, the patient actually harbored a high‐grade sarcoma, and in each case, they were followed into their grave by their clinician with the errant diagnosis of “ganglion”. It is not overtly surprising that neoplasms masquerading [...]

Needle Aspiration Biopsy2017-11-25T09:16:05+00:00

Current Concepts in Psoriasis Therapy

2017-11-25T09:10:43+00:00

Largely unchanged for decades, treatment methods for this potentially disabling condition are finally evolving Introduction Our ability to treat adverse medical conditions has long been an admixture of miraculous accomplishment and frustrating stagnation. For every disease such as osteogenic sarcoma, where recent therapeutic breakthroughs have lifted cure rates from 10-20% to over 90%, there is a condition like pulmonary adenocarcinoma, where cure rates approach their historic controls. The management of dermatologic disorders has not offered any particular exception to this rule. There recently have been profound advances in the medical management of inflammatory conditions of the skin; however, many of [...]

Current Concepts in Psoriasis Therapy2017-11-25T09:10:43+00:00
Onychodystrophy Molecular Assay now includes Pseudomonas aeruginosaLEARN MORE
+ +